KFDA approves marketing authorization for combination antiplatelet product containing aspirin with c

CJ Cheiljedang Corp. announced last Friday the approval of their dual antiplatelet combination capsule CrossOne (clopidogrel and acetylsalicylic acid) by the Korea Food and Drug Administration.

With the introduction a double SODAS (spheroidal oral drug absorption system) technology, CrossOne has a two-layer coating for patient compliance; clopidogrel with an IR (immediate release) layer coat...